• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    Anti-ulcer agents of the formula <IMAGE> I wherein R1 is a straight or branched chain alkynyl group containing from 3 to 9 carbon atoms, inclusive, are prepared by reacting a compound of the formula <IMAGE> II wherein X is a conventional leaving group, preferably in the form of its acid addition salt, with a compound of the formula <IMAGE> III wherein R1 is as defined above. The intermediates of Formula III may be prepared by reacting a cysteamine salt with an isothiourea of the formula <IMAGE> V wherein R1 is as described above, in the presence of a base.
    公开号:SU900809A3
    申请号:SU782625004
    申请日:1978-06-02
    公开日:1982-01-23
    发明作者:Рэй Креншо Ронни；Майкл Льюк Джордж
    申请人:Бристоль-Мейерз Компани (Фирма)；
    IPC主号:
    专利说明:

    39 where R is lower alkyl ,. aryl, substituted aryl, -QijCN or, where R is hydrogen or lower alkyl, with the selection of the target product in free form or in the form of a salt. In this connection, the compounds of the formulas (II) and (III) are preferably used in equimolar amounts, Example 1. And-lac N p -D2-C (4-methyl 5-imidazolyl) methyltyoethyl N-propargylguanide. A mixture of M-cyano-N - {2 14-methyl-5-imidazolyl methylthio eTyl - $ - methylisothiourea (3.00 g, 0.01 And mol with propargylamine (2.50 g of 0.045 mol in addetonitrile (60 ml) is stirred at reflux for 65 h, and then it is heated in a stainless steel high-pressure apparatus at J20ISO C for 38 h. The reaction mixture is cooled, decanted from the resin and then evaporated to give a gummy product g). This product is placed into a column filled with silica gel (100-200 mesh) and eluted with a mixture of methylene chloride (97 parts) and methanol (3 parts). The product obtained from the middle fraction is crystallized by mixing with acetonitrile and then recrystallized from acetonitrile to obtain the proposed compound in an amount of 0.236 g, yield 7.7%, mp 146-149. : C 52.15, H 5.83; N 30.41. C, and C (. NfcS Found,%: C 5.86} H 5.81 N 30.70., Example 2. K-Cyano-M - {2 (4-methyl-5-imidazole 1) methyLthio ethyl} M-propargylguanidine. A) N-cyano-N-propargyl-3-methylisothiourea (A). A solution of dimethyl cyano-dithioimino bonate (16.00 g, 0.109 mol) and propargylamine (6.03 g 0.109 mol) in acetonitrile (320 ml) is stirred under heating with reflux for 4 h, and then at 25 ° C for 12. Compound (A) is obtained in the amount of 13.58 g (81% m.p. 160-164 ° C. B) H-cyano-H-2 (4-methyl-5-imide azolyl) methylthio ethyl} K-propargylguid anidine. A solution of compound (A) (11.71 g, 0.0765 mol) of 2- (4-methyl-5-imidazolyl) methyl thio ethylamine (13.10 g, 0.0756 mol) in methanol (250 ml) is heated in reverse reflux for 64 hours. The solvent is removed by evaporation, the precipitate is introduced into a column filled with silica gel (100-200 mesh) and chromatographed using elution with methylene chloride / methanol, the last fractions give 4.0 g of the desired compound. recrystallization from acetonitrile, a purified product was obtained with mp. 150152, identical (according to infrared nuclear magnetic resonance and thin layer chromatography) to the product prepared in Example 1. f Example 3. H-Cyano-H- {2 (4-methyl-5-imidazolyl) methylthioZ ethyl} N - ( 2-butin-1-yl) guanidine. a) N- (2-ytin-l-yl) -N-cyano-S-methylisothiourea (B). A solution of dimethyl cyanodothiaminocarbonate (10.00 g, 0.0684 mol) and 2-butyn-I-amine (4.73 g, 0.0684 mol) in acetonitrile (200 ml) is stirred for half an hour, and then heated with reverse draining reflux for 2.5 hours. The mixture is cooled and then filtered to give the title compound (c) with mp. 180-183 ° C. b) N-UHaHO-N- (2 (4- IethIHG-5-imidazolyl) methylthio} ethyl} L- (2-butyl-l-yl) hyanidine. Solution of compound (B) (6.82 g; 0.0407 mol) and 2- (4-methyl-5-imidazolyl) methylthio ethylamine (6.98 g; 0.0407 mol) in methanol (140 ml) are heated with reflux for 40 h. Treatment and chromatographic separation according to example 2 give the desired product, mp 128-130 0. Example 4. M-Cyano-H - {2-methyl-5-imidazolyl) methylthioZethyl (3-butin-1-yl) guanidine. The preparation of the product is carried out as in Example 1, except that an equal amount of 3-butyn-1-amine is used instead of propargylamine, as a result of which the desired product is obtained in the title). Example 5. N-UHaHo-N - {2 (4-methyl-5-imidazolyl) methylthio-methyl (4-pentyl-1-yl) y vanidine. The product was prepared as described in Example 1, with the exception that instead of propargylamine, an amount of 4 pentyl-1-amine was used equally, a substance with m.p. Example 6. N-cyano-N - (2 (4-methyl-5-1azolyl) methyl ethyl ethyl (2-methyl-3-butyn-2-yl) guanidine. The compound was prepared according to example 3 with the exception that instead of 2-butyl-1-amine, an equimolar amount of 1,1-dimethylpropangylamine is used. Example 7. S-cyano (2 (4-methyl-5-imidazolyl) methylthio ethyl | S - (3-6utin-2-yl) guanidine. The product was prepared as described in Example 3, except that an equimolar amount of 1-methylpropargylamine was used instead of 2-butyn-I-amine. J. Example 8. Y-Cyano-K - (2 (4-methyl-5-imidazolyl ) methylthio ethyl H - (2-butyl-1-yl) guanidine. A mixture of H-cyano-S - {2 (4-ethyl-.-im Ndazolyl) methylthio ethyl-S-methylisothiourea (3.00 g, 0.0111 mol and 2-butyn-1-amine (3.07 g, 0.0445 mol) in 60 ml of propionitrile is stirred under heating with refluxing reflux for 40 h. The study of an aliquot of the reaction mixture by thin layer chromatography revealed a trace of the original isothiourea, so the mixture is heated to reflux for 6 h, and then stirred at room temperature for 64 h. The solvent (along with the excess amine) is removed under reduced pressure, and the resulting residual the sheet product is introduced into a silica gel column (100-200 mesh) and eluted with a mixture of methylene chloride (97 parts) and methanol (3 parts). The middle fractions are combined and evaporated, resulting in 1.8 g of a yellow resinous substance. This resinous substance is dissolved in 20 ml of ethyl acetate, and it crystallizes out at -15 ° C. The resulting pale yellow solid (1.2 g) is dissolved in 11 ml of hot acetonitrile and recrystallized at -15 ° C, the yield is em 1,072 g, so pl. 128-130 ° C. The results of the analysis. Calculated,%: C 3.77, H 6.25 N 28.94 S 1.08. , j NfcS. Found 7: C 53.72; H 6.29; N $ 29.62 S 11.34. . , Example 9. N-UHaHO-N - (2 (4-methyl-5-imidazolyl) methylthio ethyl) M - (3-bu-tin-yl) g uanidine. A mixture of N-cyano-M (4-ethyl-5-imidazolyl) methylthio-ethyl} -5-methyl-isothiourea (3.00 g, 0.0111 mol) and 3-butyn-1-amine (3.13 g, 0.0453 mol ) in 60 ml of propionitrile is stirred while heating with reflux reflux for 40 hours. The solvent is evaporated, resulting in 5.40 g of syrup, which is introduced into a column of silica gel (70 g, 100-200 mesh) and subjected to chromatographic separation by elution with methylene chloride / methanol. The results of the chromatographic separation are shown in the table.
    9008098
    j Continuation of the table
    Note. NWOI -. “Em lool alcohol.
    Thin layer chromatography | silicon, silica gel, euueroe a mixture of 90 CH Clj / lO MeOH shows pure fractions 9-12, which must be connected. Fractions 1-8 detect; there are persistent mobile n imides. Fractions 13 and 14 have some traces of impurities. Fractions 9–12 were combined and evaporated to give 1.72 g of a yellow, gummy product, which was then dissolved in 1 ml of nitromethane, and it was used at a temperature (pale yellow solid weighing 1.18 g). The product is then recrystallized from 9 ml of imitrometha, after which the product yield is 0.987 g, m.p. 86-89 ° C (softening temperature). The infrared spectrum and the spectrum of a nuclear magnetic resonance (100 MHz) shows that it is a pure product with the desired structure. The nuclear magnetic resonance spectrum shows that this product is solvated from about 0.08 mol of nitromethane.
    The results of the analysis.
    Calculated,%: C 53.21-, H 6.22, N 28.841 S Yu, 86.
    C "H"% S 0.08 (aiiNOt)
    Found%: C 52.68i 52.87, H 6.28 6.02 | N 29.391 29.30 S 11.22,
    P Romer 10. Y-Cyano-H - (2 and 4- "ethyl-5-imidazolyl) methyl thio ash N - (4-penten-l) guanidine.
    权利要求:
    Claims (2)
    [1]
    a mixture of M-cyano-K - (2 g (4-methyl-5-ymidazolyl) methylthioZ ethyl} -5-methyl-euteo-urea (3.00 g 0,0111 mol) and 4-p-third-I-amine (3.69 g } 0.0445 mol) in 60 ml of acetonitrile is heated under reflux for 24 hours and then maintained at a commanding temperature of 96 hours: The solvent and the excess amine are removed under reduced pressure, the residual yellow resin is purified by chromatography on a column, filled with silica gel (50 g | 100-200 mesh), carried out sequential elution of methylene chloride with methanol (99: 1-96: 4). The average fractions that were as indicated by chromatographic separation, they are combined and evaporated, yielding 1.91 g of a yellow resinous substance, which crystallizes at a temperature of 18 ml of ethyl acetate. The resulting white solid (1.25 g) is recrystallized at -15C temperature from 10 ml of acetonitrile, resulting in a yield of 1.063 g of product, mp 99-103 C. The results of the analysis: Calculated,%: C 55.24; H 6.52, N 27.61-, S 10.53. H HjoNfcS Found: C 55.43; H 6.58; N 28.26V S 10.97. , Example P. N-HsaHo-N - (2 C (4-methyl-5-imidazolyl) methylthio-propargylguanidine. A mixture of K-cyano-K - | 2 (4-methyl-5-imidazolyl) methylthio ethyl | -5- methylisothiouregins (g; 0.0371 mol and distilled propargylamine (20 ml D, 325 mol) in methanol (50 ml) were removed from the heat from the reaction mixture (refluxing under nitrogen overpressure (in a nitrogen stream) 20.5 h The solvent and the excess amine are then removed by evaporation to obtain a pale brown oily product which readily crystallizes. When grinding this product while dissolving in isopropane le (30 ml), an whitish compound is obtained, which consists of a short white substance (8.11 g, 79%) with a mp of 146-148.5 C. Example 12. M-Cyano-M - {2 C (4- Methyl-5-imidazolyl) methylthio eth1} H-propargylguanidine. A mixture of M-cyano-1 - (2 (.4- "ethyl-5-imidazolyl) methylthio ethyl} -S-methyl-isothioumide (100 g; 0.371 mol) and distilled propargylamine (150 ml 2.44 mol) in methanol (1500 ml) is stirred under heating with refluxing under reflux under an overpressure of nitrogen (under a stream of nitrogen) for 22 hours. The reaction mixture is cooled, the solvent and the excess amine are removed by evaporation. Tate to give succinic oily produk which easily crystallized. This crude product is triturated while dissolving in isopropanol (250 ml), cooled at 2 hours and removed by filtration. The sludge left on the filter is washed with cold isopropanol and 9 is dried under vacuum at Pj 0 $ for 16 hours. The dried product required is presented em is an almost white solid, its yield is 73.5 g (71.7%), so pl. 147149 ° C. Example 13. Recrystallization of N-cyano-N - {2 G (4-methyl-5-imidazolyl) methylthio ethyl} S-propargilgunidine. The final products obtained in Examples 11 and 12 were combined (the total amount was 81.3 g), dissolved in hot isopropanol (1000 ml), filtered through Supercelite and cooled at room temperature for 68 hours. The resulting crystalline product recovered by filtration, washed with cold isopropanol, crushed and dried in a heated desiccator under high vacuum for 45 hours. The product yield was 72.4 g (regeneration degree .89%), mp. 149-151 s. Analysis by preparative thin layer chromatography shows a product purity of about 99.5%. The nuclear magnetic resonance spectrum (100 MHz) shows the purity of the product, which corresponds to the data of chromatographic analysis. The results of the analysis. Calculated,%: C 52.15, H 5.83 j N 30 41-S P 60. C ii N S «« Found,%: C 52.42; H 5.94, N 30.51 j S 11.35. Claims 1. Method for producing N-nHaHo-N - {2- (4-methyl-5-imidazolyl) methylthio ethyl} N -alkynylguanidines of the general formula I CI, (I 1 NCN A / H..... SC SC CW / VHCNH R lkinil with a straight or branched chain containing 3-9 carbon atoms, or their salts, characterized in that the compound of the formula P IL il Ni Cb25CHCW / VW- 5 C or VIS where where the substitute 11, 90080912 his co-pi undergo interaction - where R is hydrogen or lower with Shalkyl compound of the form, d jyjun by isolating the desired product in I free form or as a salt, R has the indicated values; j
    [2]
    2. The method according to claim 1, different from RJ and RJ, is not the same and represents and because the compounds are either a hydrogen atom, jw II and III are used in equal quantities or group quantities. -C: Sources of information, Sfl O taken into account in the examination of R means lower alkyl, aryl, I. Laid for FGD 234L779, puppy aryl, -QijCN or -QljCOORkl. C 07 D 233/64, published 1979
    类似技术:
    公开号 | 公开日 | 专利标题
    ES8307749A1|1983-08-16|Thromboxane synthetase inhibitors, processes for their production, and pharmaceutical compositions comprising them.
    SU900809A3|1982-01-23|Process for preparing n-cyano-n&#39;- 2-/| methylthio/ethyl n&#39;&#39;-alkenylguanidines or their salts
    RU1797610C|1993-02-23|Process for preparing | guanidines or pharmaceutically acceptable salts thereof
    SU578884A3|1977-10-30|Method of preparing triazoleisoindole derivatives
    SU663299A3|1979-05-15|Method of obtaining n-benzil-2,3-dimethoxyacetamines
    EP0009608B1|1982-04-21|N-phenethylacetamide compounds, processes for their preparation and therapeutic compositions containing them
    US4325886A|1982-04-20|Optical resolution of acylthiopropionic acid
    CA1167455A|1984-05-15|Process for preparing n-acylcarnosine
    SU649308A3|1979-02-25|Method of obtaining triazapentadiene derivatives or salts thereof
    EP0239194A3|1987-11-11|Methods for preparing hydroxy compounds and intermediates
    EP0256745B1|1992-05-13|Crystalline complex compounds of propargyl alcohols and tertiary diamines, and process of separation and purification of propargyl alcohols using the same
    US3461131A|1969-08-12|Process for preparing 2-substituted cycloheptimidazole derivatives
    US4849512A|1989-07-18|3-acylamino-3-deoxyallose derivatives
    US5453529A|1995-09-26|Nitroimino compound as intermediate for insecticides and pharmaceuticals
    CA1297878C|1992-03-24|Process for the obtention of the ethyl ester of the apovincaminic acid
    EP0053584B1|1985-04-17|Raceme sulpiride resolution process
    EP0062068B1|1985-06-12|N-phthalidyl-5-fluorouracil derivatives
    EP0410224B1|1996-01-10|Pyrrolo [2,1-b]thiazole derivatives
    US3472850A|1969-10-14|Method for the production of 2-substituted - 4 - amino - 5 - acylamidomethyl-pyrimidine
    US4552967A|1985-11-12|Process for the synthesis of intermediates in the preparation of diaminopyridines
    US4339379A|1982-07-13|N-Acrylcarnosine aluminum salts
    SU679143A3|1979-08-05|Method of producing arylaminopyrimidine derivatives
    Kieć-Kononowicz et al.1989|Reaction of 5, 5-diphenyl-2-thiohydantoin with 1, 4-dibromobutane. The crystal and molecular structure of 2, 3, 4, 5-tetrahydro-7, 7-diphenylimidazo-[2, 1-b]-thiazepine-8 |-one
    US4125728A|1978-11-14|Method for preparing 2,3,7,8-tetraazaspiro[4,4]nona-2,7-diene
    PL93734B1|1977-06-30|
    同族专利:
    公开号 | 公开日
    AU3681678A|1979-12-06|
    AU516144B2|1981-05-21|
    JPS595581B2|1984-02-06|
    US4158013A|1979-06-12|
    JPS5737589B2|1982-08-10|
    AT363955B|1981-09-10|
    JPS55157562A|1980-12-08|
    ATA404378A|1981-02-15|
    ZA783141B|1979-06-27|
    HU182645B|1984-02-28|
    JPS55157559A|1980-12-08|
    BE867594A|1978-11-29|
    US4157347A|1979-06-05|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    US2697727A|1953-04-28|1954-12-21|American Cyanamid Co|Method of preparing s-alkyl cyanopseudothioureas|
    GB1338169A|1971-03-09|1973-11-21|Smith Kline French Lab|Ureas thioureas and guanidines|
    GB1399283A|1972-04-20|1975-07-02|Smith Kline French Lab|Pharmaceutical compositions|
    US3897555A|1972-05-22|1975-07-29|Smithkline Corp|Pharmaceutical compositions and method of inhibiting gastric acid secretion|
    BE804144A|1972-09-05|1974-02-28|Smith Kline French Lab|H-2-Receptor antihistamines esp gastric acid inhibitors - -N-cyano-N"--guanidines|
    US4093621A|1974-09-02|1978-06-06|Smith Kline & French Laboratories Limited|Process for preparing heterocyclicalkylthioalkyl-N-cyanoguanidines and thioureas|
    GB1533380A|1974-09-02|1978-11-22|Smith Kline French Lab|Process for the preparation of heterocyclic substituted thioureas and h-cyanoguanidines|
    GB1553070A|1975-05-21|1979-09-19|Smith Kline French Lab|Thiourea guanidine and 1-nitro-2,2-diaminoethylene derivatives|
    GB1578219A|1975-12-01|1980-11-05|Smith Kline French Lab|Isothioureas|
    JP4626483B2|2005-10-27|2011-02-09|ソニー株式会社|Server apparatus, data processing method, program, and communication method|
    JP4641293B2|2006-08-25|2011-03-02|本田技研工業株式会社|Overheat protection device for saddle-ride type vehicles|USRE31588E|1977-06-03|1984-05-22|Bristol-Myers Company|Imidazolylmethylthioethyl alkynyl guanidines|
    JPS6125026B2|1978-08-31|1986-06-13|Sogo Yatsuko Kk|
    US4431802A|1979-12-10|1984-02-14|G. D. Searle & Co.|N-Heterocyclyl-N-cyano-N--guanidines|
    US4239908A|1979-12-10|1980-12-16|G.D. Searle & Co.|N-aralkenyl-N'-cyano-N"--guanidines|
    DE3014353A1|1980-04-15|1982-01-21|Bayer Ag, 5090 Leverkusen|TRISUBSTITUTED CYANGUANIDINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS FUNGICIDES|
    ES521588A0|1983-03-30|1984-08-16|Ferrer Int|PROCEDURE FOR OBTAINING NEW N-CIANO-FORMAMIDINES.|
    US4588719A|1984-04-27|1986-05-13|William H. Rorer, Inc.|Bicyclic benzenoid aminoalkylene ethers and thioethers, pharmaceutical compositions and use|
    WO2022034121A1|2020-08-11|2022-02-17|Université De Strasbourg|H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    US80300977A| true| 1977-06-03|1977-06-03|
    [返回顶部]